Idenix Pharmaceuticals , Inc. ( IDIX ) Deutsche Bank BioFEST ..... Chief Medical Officer of Idenix Pharmaceuticals . So I had some questions ..... com/article/1872301- idenix - pharmaceuticals -management-presents
Idenix Pharmaceuticals ( IDIX -5% ) announced earlier that it has filed two lawsuits against ..... is likely to be minimal . "Though this could potentially provide IDIX another means of challenging GILD, we expect the process to be lengthy
Wall Street Breakfast Editors submit: Top Stories Thanksgiving weekend sales slip. Consumers spent an estimated $57.4B over the Thanksgiving weekend, down 2.7% from last year, the National Retail Federation has estimated. However, the number of shoppers increased to 141M people from 139M. The fall
By Markus Aarnio : In this article, I will feature one biotech stock that has seen intensive insider buying during the last 30 days. Intensive insider buying can be defined by the following three criteria: The stock is purchased by three or more insiders within one month. The stock is sold by no ...
By John Vincent : This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's U.S. stock portfolio on a quarterly basis. It is based on Klarman's regulatory 13F Form filed on 11/13/2013. Please visit our Tracking Seth Klarman's Baupost Group Holdings ...
thinks the rally in shares of Idenix Pharmaceuticals ( IDIX +41% ) may be attributable ..... weekend. Here's Young: " IDIX has noted that they are not interested ..... would be interested in a nuke." IDIX 's HELIX-1 trial is evaluating
Top 10 Gainers: SCKT +37% . IDIX +38% . HXM +33% . OSIR +25% . IRIX +22% . FSLR +18% . GDOT +16% . DRAD +16% . TRMB +14% . GNK +14% . Top 10 Losers
Shares of Idenix Pharmaceuticals ( IDIX +32.8% ) are on-the-move this morning, trading sharply ..... and GT4 trial) with SVR4 data expected in Q4. Also of note, IDIX said its cash "will be sufficient to sustain its operations
Idenix Pharmaceuticals , Inc. ( IDIX ) Q3 2013 Earnings Conference Call October 30 ..... gentlemen and welcome to the Idenix Pharmaceuticals Reports Third Quarter Financial ..... com/article/1790842- idenix - pharmaceuticals -ceo-discusses-q3
Idenix ( IDIX ): Q3 EPS of -$0.25 misses by $0.04 . Revenue of $19K. ( PR ) Post your comment!